Citations

Showing 10 of 108119 citations.

1047 Caught on Camera: Interpretation of Polysomnogram
Kwon, Minkyung , Arunthari, Vichaya, Colaco, Brendon

Mayo Clinic

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A420-A420

10.1093/sleep/zsz069.1044 Get It

1065 NEW DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA FOLLOWING ANTERIOR CERVICAL DISCECTOMY AND FUSION, WORSENED BY RHEUMATOID ARTHRITIS
Wasey, Waiz, Festić, Emir , Castillo, Pablo

Mayo Clinic

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A426-A427

10.1093/sleep/zsz069.1062 Get It

1077 Epidural Abscess in a 9 Year Old Boy on Continuous Positive Airway Pressure Therapy
Edlund, Wendy

Mayo Clinic

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A430-A431

10.1093/sleep/zsz069.1074 Get It

Response to “Colorectal Cancer Screening by Stool DNA Testing and Patient Emotional Health”
Eckmann, Jason D. , Kisiel, John B.

Mayo Clinic

American Journal of Gastroenterology | April 13, 2019 | Volume: 114 | Issue: 5 | Pages: 829-830

10.14309/ajg.0000000000000218 | PMID 30950841 Get It

Response to Chapman and Jones
Lichtenstein, Gary R. , Loftus, Edward V. , Isaacs, Kim L. , Loftus, Edward V , Regueiro, Miguel , Sands, Bruce E

Mayo Clinic

American Journal of Gastroenterology | April 13, 2019 | Volume: 114 | Issue: 5 | Pages: 828-828

10.14309/ajg.0000000000000217 | PMID 30985301 Get It

Response to Ribaldone
Lichtenstein, Gary R. , Loftus, Edward V. , Isaacs, Kim L. , Loftus, Edward V , Regueiro, Miguel , Sands, Bruce E

Mayo Clinic

American Journal of Gastroenterology | April 13, 2019 | Volume: 114 | Issue: 5 | Pages: 826-827

10.14309/ajg.0000000000000216 | PMID 30985300 Get It

A Rare Case of Systemic Adult Burkitt Lymphoma Presenting as Acute Acalculous Cholecystitis
Doherty, Bryan, Palmer, William C. , Cvinar, Jessica, Sadek, Nora

Mayo Clinic

ACG Case Reports Journal | April 13, 2019 | Volume: 6 | Issue: 4 | Pages: e00048

10.14309/crj.0000000000000048 | PMID 31616732 Get It

ABSTRACT Acute acalculous cholecystitis (AAC) is an uncommon presentation of cholecystitis accounting for 10% of cases. AAC is caused by a localized ischemic event in the gallbladder usually in critically ill patients. Several cases of localized or systemic lymphoma have been described in the literature as causes of AAC. We present a patient with a rare case of AAC due to undiagnosed systemic Burkitt lymphoma. Pathology of the gallbladder revealed Burkitt lymphoma with analysis of his cerebral spinal fluid confirming Stage IV disease. This case report reviews acute acalculous cholecystitis, lymphomas of the gallbladder and extrahepatic duct, and adult Burkitt lymphoma.
A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial
Chey, William D. , Lacy, Brian E. , Epstein, Michael, Corsino, Patrick, Lacy, Brian E. , Cash, Brooks D. , Shah, Syed Mahboob Ali

Mayo Clinic

Clinical and Translational Gastroenterology | April 13, 2019 | Volume: 10 | Issue: 4 | Pages: e00021

10.14309/ctg.0000000000000021 | PMID 30939487 Get It

OBJECTIVES: We conducted a randomized, placebo-controlled trial, which evaluated a novel formulation of caraway oil and L-menthol using microsphere-based site-specific targeting (COLM-SST) vs placebo in patients with functional dyspepsia (FD). METHODS: Adult men and women with FD defined by Rome III criteria were recruited. Patients were randomized to COLM-SST (25 mg of caraway oil and 20.75 mg of L-menthol per capsule, at 2 capsules per dose, twice per day) or placebo. Efficacy was measured at 24 hours, 2 weeks, and 4 weeks. Patients were allowed to take concomitant medications for their FD throughout the trial, and rescue medicines were allowed, 48 hours after start of dosing. RESULTS: Ninety-five patients were enrolled (mean age = 43.4 years; 75.8% women). At 24 hours, the active arm reported a statistically significant reduction in postprandial distress syndrome symptoms ( P = 0.039), and a nonsignificant trend toward benefit of epigastric pain syndrome symptoms ( P = 0.074). In patients with more severe symptoms, approximately 3 quarters of patients showed substantial global improvement (i.e., clinical global impressions), after 4 weeks of treatment, vs half in the control arm. These differences were statistically significant for patients with epigastric pain syndrome ( P = 0.046), and trending toward significance for patients with postprandial distress syndrome ( P = 0.091). There was no statistically significant difference between groups for Global Overall Symptom scores for the overall population at 2 and 4 weeks. Treatment emergent adverse events were mild to moderate, and no serious adverse events were reported. DISCUSSION: In patients taking their usual medications for FD, COLM-SST provided rapid relief (within 24 hours) and relief of severe FD symptoms. It was safe and well tolerated.
Reducing Iatrogenic Pneumothoraces: Using Real-Time Ultrasound Guidance for Pleural Procedures
Fritz, Ashley Virginia , Tatari, Mehmet M. , Díaz‐Gómez, José L. , Fritz, Ashley V, Daniels, Craig E, Díaz-Gómez, José L , Helgeson, Scott A. , Daniels, Craig

Mayo Clinic

Critical Care Medicine | April 13, 2019 | Volume: 47 | Issue: 7 | Pages: 903-909

10.1097/ccm.0000000000003761 | PMID 30985389 Get It

Objectives: Awareness of the impact of bedside ultrasound to reduce iatrogenic pneumothoraces while performing bedside pleural procedures has increased but with little understanding in how ultrasound is used for these procedures. Design and Setting: We conducted a retrospective chart review at a tertiary referral center in the United States from January 1, 2014, to March 31, 2017. Our study assessed adverse effect rates between real-time ultrasound-guided and ultrasound-marked thoracenteses and thoracostomy tube placements. Patients: Three-hundred ninety-four ICU patients were included in this study. Measurements and Main Results: There was a significant difference in the rate of adverse effects between real-time ultrasound-guided (0.63% [95% CI, 0.11–3.4%]) and ultrasound-marked (6.89% [95% CI, 4.15–11.24%]; p ≤ 0.01) procedures. More specifically, the rate of pneumothoraces was different between the two procedures (0.63% [95% CI, 0.11–3.4%] vs 4.43% [95% CI, 2.35–8.21%]; p = 0.02). In patients mechanically ventilated, there was a significant difference in overall adverse effect rates between groups of ultrasound use ( p = 0.01). Conclusions: The use of real-time ultrasound guidance was associated with a lower rate of iatrogenic pneumothoraces.
Altered Physical Performance Following Advanced Special Operations Tactical Training
Winters, Joshua D. , Johnson, Alexa K. , Poploski, Kathleen M. , Royer, Scott D., Nagai, Takashi , Randall, Carson A., Abt, John P. , Lephart, Scott M., Nagai, Takashi , Heebner, Nicholas R.

Mayo Clinic

Journal of Strength & Conditioning Research | April 13, 2019 | Volume: 35 | Issue: 7 | Pages: 1809-1816

10.1519/jsc.0000000000003087 | PMID 30985522 Get It

Abstract Winters, JD, Heebner, NR, Johnson, AK, Poploski, KM, Royer, SD, Nagai, T, Randall, CA, Abt, JP, and Lephart, SM. Altered physical performance following advanced special operations tactical training. J Strength Cond Res 35(7): 1809–1816, 2021—The purpose of this study was to determine how the unique challenges of specific military tactical training phases influence overall physical performance characteristics. Broad jump, 5-10-5, 300-yd shuttle, percent body fat (%BF), anaerobic power (AP) and anaerobic capacity (AC), maximal oxygen uptake (V̇ o 2 max), isokinetic knee extension/flexion strength, shoulder internal/external rotation strength, and trunk extension/flexion strength were collected on 73 United States Marine Corps Forces Special Operations Command (MARSOC) students (age: 27.4 ± 3.8 years, height: 178.7 ± 6.6 cm, and body mass: 85.8 ± 9.4 kg) at the beginning of (P1), in between (P2), and at the completion of 2 distinct tactical training phases (P3). Linear mixed models were used to analyze within-subject performance changes over the 3 time points, and post hoc Bonferroni pairwise comparisons analyzed performance changes between each testing time point. There were significant changes in broad jump ( p < 0.0001), 5-10-5 agility time ( p < 0.001), %BF ( p = 0.011), AP ( p < 0.0001), V̇ o 2 max ( p = 0.001), and both right and left shoulder internal rotation strength ( p = 0.004 and p = 0.015, respectively) between P1 and P2. There were also significant changes in 300-yd shuttle run time ( p = 0.001), AP ( p < 0.0001), AC ( p < 0.0001), left knee extension strength ( p = 0.006), trunk flexion strength ( p < 0.0001), and left shoulder external rotation strength (0.027) between P2 and P3. Identifying the effect that specific tactical training phases may have on physical performance will allow for the development of effective phase-specific evidence-based human performance programs, reducing performance deficits and thereby reducing the risk of injury.